Exparel - risks and mitigations

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org

4 posts / 0 new
Last post
Killian Hanley
Killian Hanley's picture
Last seen: 2 months 22 hours ago
Joined: 10/18/2021 - 22:51
Exparel - risks and mitigations

Hello all,
We are reviewing a request to add Exparel to formulary at our pediatric hospital. There are 2 main concerns we have with this medication: 1. Cannot administer a local anesthetic for 96 hrs after Exparel administration due to toxicity, 2. Looks like propofol but cannot be given IV so concern for wrong route error and harm.

If your institution has Exparel on formulary, what mitigations do you have in place to prevent these errors from reaching the patient?

Thank you in advance!